It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BLCO’s FA Score shows that 1 FA rating(s) are green whileSRDX’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BLCO’s TA Score shows that 4 TA indicator(s) are bullish while SRDX’s TA Score has 5 bullish TA indicator(s).
BLCO (@Medical Specialties) experienced а -13.40% price change this week, while SRDX (@Medical Specialties) price change was -1.63% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -4.68%. For the same industry, the average monthly price growth was +1.30%, and the average quarterly price growth was +1.15%.
BLCO is expected to report earnings on Apr 30, 2025.
SRDX is expected to report earnings on Apr 30, 2025.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
BLCO | SRDX | BLCO / SRDX | |
Capitalization | 6.07B | 397M | 1,529% |
EBITDA | 499M | 22.1M | 2,258% |
Gain YTD | -28.073 | -23.965 | 117% |
P/E Ratio | 909.09 | 71.51 | 1,271% |
Revenue | 4.15B | 138M | 3,004% |
Total Cash | 331M | 35.2M | 940% |
Total Debt | 4.56B | 33.9M | 13,457% |
SRDX | ||
---|---|---|
OUTLOOK RATING 1..100 | 6 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 93 | |
PRICE GROWTH RATING 1..100 | 61 | |
P/E GROWTH RATING 1..100 | 92 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BLCO | SRDX | |
---|---|---|
RSI ODDS (%) | 1 day ago90% | 1 day ago69% |
Stochastic ODDS (%) | 1 day ago68% | 1 day ago75% |
Momentum ODDS (%) | 1 day ago71% | 1 day ago68% |
MACD ODDS (%) | 1 day ago72% | 1 day ago64% |
TrendWeek ODDS (%) | 1 day ago73% | 1 day ago70% |
TrendMonth ODDS (%) | 1 day ago79% | 1 day ago69% |
Advances ODDS (%) | 16 days ago65% | 8 days ago69% |
Declines ODDS (%) | 8 days ago73% | 24 days ago68% |
BollingerBands ODDS (%) | 1 day ago90% | 3 days ago63% |
Aroon ODDS (%) | 1 day ago85% | 1 day ago59% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BUYZ | 35.14 | N/A | N/A |
Franklin Disruptive Commerce ETF | |||
DAPR | 35.98 | -1.53 | -4.08% |
FT Vest US Equity Dp Bffr ETF Apr | |||
IUS | 47.55 | -2.15 | -4.33% |
Invesco RAFI™ Strategic US ETF | |||
PAMC | 40.83 | -2.35 | -5.45% |
Pacer Lunt MidCap Multi-Factor Alt ETF | |||
FV | 52.64 | -3.18 | -5.70% |
First Trust Dorsey Wright Focus 5 ETF |
A.I.dvisor tells us that BLCO and ITGR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BLCO and ITGR's prices will move in lockstep.
Ticker / NAME | Correlation To BLCO | 1D Price Change % | ||
---|---|---|---|---|
BLCO | 100% | -9.48% | ||
ITGR - BLCO | 32% Poorly correlated | -4.14% | ||
SYK - BLCO | 29% Poorly correlated | -2.47% | ||
IDXX - BLCO | 28% Poorly correlated | -3.63% | ||
LH - BLCO | 28% Poorly correlated | -1.23% | ||
IQV - BLCO | 28% Poorly correlated | -3.83% | ||
More |
A.I.dvisor tells us that SRDX and RMD have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SRDX and RMD's prices will move in lockstep.
Ticker / NAME | Correlation To SRDX | 1D Price Change % | ||
---|---|---|---|---|
SRDX | 100% | -2.53% | ||
RMD - SRDX | 32% Poorly correlated | -4.33% | ||
MBOT - SRDX | 26% Poorly correlated | -7.65% | ||
VNRX - SRDX | 26% Poorly correlated | +3.13% | ||
UFPT - SRDX | 26% Poorly correlated | -8.15% | ||
BLCO - SRDX | 25% Poorly correlated | -9.48% | ||
More |